LifeStance Health Group, Inc.
LFST
$6.45
-$0.08-1.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 983.38% | 128.41% | -634.70% | 109.97% | -19.39% |
| Total Depreciation and Amortization | -0.91% | -3.21% | 1.82% | -6.24% | -2.94% |
| Total Amortization of Deferred Charges | 0.39% | 0.39% | 1.59% | -37.56% | -4.29% |
| Total Other Non-Cash Items | 2.63% | -7.42% | 9.52% | -5.82% | 20.79% |
| Change in Net Operating Assets | 110.73% | -178.19% | 146.78% | -300.93% | 287.08% |
| Cash from Operations | 110.94% | -57.63% | 2,182.66% | -104.96% | 174.25% |
| Capital Expenditure | -6.02% | -32.70% | -8.19% | -13.76% | -24.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.02% | -32.70% | -8.19% | -13.76% | -24.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.06% | -0.06% | 0.06% | 99.37% | -39,202.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 53.11% | 11.44% | 97.11% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -253.01% |
| Cash from Financing | 5.54% | 1.27% | 79.47% | -145.75% | -100.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 198.78% | -72.57% | 369.79% | -138.95% | 232.07% |